Published in Crit Rev Eukaryot Gene Expr on January 01, 1998
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest (1999) 7.66
Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1). J Clin Immunol (1999) 2.79
Osteoimmunology: interactions of the bone and immune system. Endocr Rev (2008) 2.32
Identification of cell cycle-arrested quiescent osteoclast precursors in vivo. J Cell Biol (2009) 1.15
Induction of colony-stimulating factor expression following Staphylococcus or Salmonella interaction with mouse or human osteoblasts. Infect Immun (2000) 1.08
Novel targets for interleukin 18 binding protein. Ann Rheum Dis (2001) 0.95
Transplantation of SHED prevents bone loss in the early phase of ovariectomy-induced osteoporosis. J Dent Res (2014) 0.85
Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev (1999) 7.69
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest (1999) 7.66
Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone (2002) 2.40
Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun (1999) 2.28
Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology (1999) 2.11
Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus. FEMS Microbiol Lett (1992) 1.99
Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology (1998) 1.75
A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology (1998) 1.75
Molecular analysis of a gentamicin resistance transposonlike element on plasmids isolated from North American Staphylococcus aureus strains. Antimicrob Agents Chemother (1990) 1.71
Effects of parathyroid hormone on Wnt signaling pathway in bone. J Cell Biochem (2005) 1.71
Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone (1999) 1.66
Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology (2001) 1.66
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology (2000) 1.61
Detection and characterization of IS256, an insertion sequence in Staphylococcus aureus. J Gen Microbiol (1987) 1.52
IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol (2001) 1.52
Cloning and expression of Staphylococcus aureus plasmid-mediated quaternary ammonium resistance in Escherichia coli. Antimicrob Agents Chemother (1985) 1.50
Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res (2001) 1.47
Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. J Clin Invest (1998) 1.44
Whose responsibility is it to assess cardiovascular risk in patients with rheumatoid arthritis? Intern Med J (2014) 1.38
Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum (2000) 1.37
Plasmid-mediated resistance to gentamicin in Staphylococcus aureus: the involvement of a transposon. J Med Microbiol (1987) 1.33
Structure of the 5' flanking region of the gene encoding human parathyroid-hormone-related protein (PTHrP). Gene (1989) 1.31
Calcitonin receptor antibodies in the identification of osteoclasts. Bone (1999) 1.29
Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. J Bone Miner Res (2000) 1.25
Importin beta recognizes parathyroid hormone-related protein with high affinity and mediates its nuclear import in the absence of importin alpha. J Biol Chem (1999) 1.24
4',4'' adenyltransferase activity on conjugative plasmids isolated from Staphylococcus aureus is encoded on an integrated copy of pUB110. Plasmid (1991) 1.22
Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes. Bone (2010) 1.21
PC8 [corrected], a new member of the convertase family. Biochem J (1996) 1.16
Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization. J Bone Miner Res (1992) 1.14
Parathyroid hormone-related protein: biochemistry and molecular biology. Crit Rev Biochem Mol Biol (1991) 1.13
Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation. Br J Haematol (2004) 1.11
Characterisation of sin, a potential recombinase-encoding gene from Staphylococcus aureus. Gene (1994) 1.11
Transforming growth factor beta stimulation of parathyroid hormone-related protein (PTHrP): a paracrine regulator? Mol Cell Endocrinol (1993) 1.07
Cell-specific and regulator-induced promoter usage and messenger ribonucleic acid splicing for parathyroid hormone-related protein. Endocrinology (1996) 1.04
Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo. Bone (2002) 1.02
Detection of an integrated tetracycline resistance plasmid in the chromosome of methicillin-resistant Staphylococcus aureus. J Gen Microbiol (1986) 1.02
A novel osteoblast-derived C-type lectin that inhibits osteoclast formation. J Biol Chem (2001) 1.01
The generation of highly enriched osteoclast-lineage cell populations. Bone (2002) 1.00
Communication between ephrinB2 and EphB4 within the osteoblast lineage. Adv Exp Med Biol (2010) 0.97
Epidermal growth factor-stimulated parathyroid hormone-related protein expression involves increased gene transcription and mRNA stability. Biochem J (1995) 0.96
Antibiotic resistance in Staphylococcus aureus isolated at an Australian hospital between 1946 and 1981. J Med Microbiol (1985) 0.96
Expression of parathyroid hormone-related protein in cells of osteoblast lineage. J Cell Physiol (1996) 0.95
Multiresistant Staphylococcus aureus: genetics and evolution of epidemic Australian strains. J Antimicrob Chemother (1988) 0.95
Antibiotic susceptibilities and plasmid profiles of nosocomial methicillin-resistant Staphylococcus aureus: a retrospective study. J Med Microbiol (1984) 0.94
Mechanisms involved in skeletal anabolic therapies. Ann N Y Acad Sci (2006) 0.94
Increased expansion of the lung stimulates calmodulin 2 expression in fetal sheep. Am J Physiol Lung Cell Mol Physiol (2002) 0.92
Osteoclasts from human giant cell tumors of bone lack estrogen receptors. Endocrinology (1998) 0.91
Prolonged hypocalcemia following denosumab therapy in metastatic hormone refractory prostate cancer. Bone (2013) 0.90
Receptor activator of nuclear factor kappa B ligand (RANKL): another link between breast and bone. Trends Endocrinol Metab (2001) 0.89
Phosphorylation at the cyclin-dependent kinases site (Thr85) of parathyroid hormone-related protein negatively regulates its nuclear localization. J Biol Chem (1999) 0.89
Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus. Intern Med J (2006) 0.89
Parathyroid hormone-related protein. Crit Rev Clin Lab Sci (1995) 0.88
Molecular dissection of the importin beta1-recognized nuclear targeting signal of parathyroid hormone-related protein. Biochem Biophys Res Commun (2001) 0.88
Alternative promoter usage and mRNA splicing pathways for parathyroid hormone-related protein in normal tissues and tumours. Br J Cancer (1995) 0.87
Dynamics of leptomycin B-sensitive nucleocytoplasmic flux of parathyroid hormone-related protein. Traffic (2001) 0.85
Subtilisin-like proprotein convertases, PACE4 and PC8, as well as furin, are endogenous proalbumin convertases in HepG2 cells. J Biochem (1999) 0.85
Alternative use of bisphosphonate therapy for rheumatic disease. Curr Pharm Des (2010) 0.85
Nuclear and nucleolar localization of parathyroid hormone-related protein. Immunol Cell Biol (2000) 0.84
Identification of brain isoforms of the rat calcitonin receptor. Mol Endocrinol (1993) 0.84
Dexamethasone regulation of parathyroid hormone-related protein (PTHrP) expression in a squamous cancer cell line. Mol Cell Endocrinol (1994) 0.84
Interleukin-18 is a novel mitogen of osteogenic and chondrogenic cells. Endocrinology (2003) 0.83
Frequent loss of heterozygosity in early non-small cell lung cancers at chromosome 9p21 proximal to the CDKN2a gene. Int J Cancer (1997) 0.83
Modulation of the signal recognition particle 54-kDa subunit (SRP54) in rat preosteoblasts by the extracellular matrix. J Biol Chem (1995) 0.82
Molecular characterization of the murine cytotoxic T-cell membrane glycoprotein Ly-3 (CD8). Proc Natl Acad Sci U S A (1987) 0.82
Oestrogen enhancement of the myometrial response to exogenous parathyroid hormone-related protein (PTHrP), and tissue localization of endogenous PTHrP and its mRNA in the virgin rat uterus. J Endocrinol (1992) 0.81
Thalassemia bone disease: the association between nephrolithiasis, bone mineral density and fractures. Osteoporos Int (2013) 0.80
Parathyroid hormone-related protein (PTHrP) mRNA splicing and parathyroid hormone/PTHrP receptor mRNA expression in human placenta and fetal membranes. J Mol Endocrinol (1998) 0.80
Homozygous and hemizygous deletions of 9p centromeric to the interferon genes in lung cancer. Cancer Res (1994) 0.80
The expression of parathyroid hormone-related protein mRNA and immunoreactive protein in human amnion and choriodecidua is increased at term compared with preterm gestation. J Endocrinol (1997) 0.80
PTHrP and cell division: expression and localization of PTHrP in a keratinocyte cell line (HaCaT) during the cell cycle. J Cell Physiol (1997) 0.80
Bone biology. Baillieres Clin Endocrinol Metab (1997) 0.79
Parthenolide inhibits pro-inflammatory cytokine production and exhibits protective effects on progression of collagen-induced arthritis in a rat model. Scand J Rheumatol (2014) 0.79
The effect of gonadal status on body composition and bone mineral density in transfusion-dependent thalassemia. Osteoporos Int (2013) 0.78
Propylthiouracil therapy: an unusual cause of antineutrophil cytoplasmic antibody associated alveolar hemorrhage. J Rheumatol (1995) 0.77
A prospective study of acute inpatient gout diagnoses and management in a tertiary hospital: the determinants and outcome of a rheumatology consultation. Intern Med J (2014) 0.76
Use of sequential DTPA clearance and high resolution computerized tomography in monitoring interstitial lung disease in dermatomyositis. Br J Rheumatol (1996) 0.76
Gentamicin and antiseptic resistance in epidemic methicillin-resistant Staphylococcus aureus. Lancet (1989) 0.76
Of mice and men, recapitulation of Blomstrand's chondrodysplasia. J Clin Endocrinol Metab (2001) 0.75
Gene organization and alternative splicing of human prohormone convertase PC8. Biochem J (1998) 0.75
Evidence for the synthesis of parathyroid hormone-related protein (PTHrP) by nontransformed clonal rat osteoblastic cells in vitro. Bone (1995) 0.75
Parathyroid hormone-related protein: isolation, molecular cloning, and mechanism of action. Recent Prog Horm Res (1989) 0.75
Production of parathyroid hormone-related protein by the rat mammary gland in pregnancy and lactation. Am J Physiol (1992) 0.75
Murine Ly-3 restriction fragment length polymorphism and transcript size differences. Immunol Cell Biol (1989) 0.75
Multiple sites of synthesis and action of parathyroid hormone-related protein. Miner Electrolyte Metab (1995) 0.75
Parathyroid hormone-related protein and human papillomavirus in gynecological tumors. Int J Cancer (1994) 0.75